Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands
- PMID: 22607719
- PMCID: PMC3358177
- DOI: 10.3201/eid1806.120302
Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands
Figures
References
-
- Devine C, Brennan GP, Lanusse CE, Alvarez LI, Trudgett A, Hoey E, et al. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole. Vet Parasitol. 2012;184:37–47. 10.1016/j.vetpar.2011.08.006 - DOI - PubMed
-
- Eberhard M, Engels D. Fascioliasis. In: Heymann DL, editor. Control of communicable diseases manual, 19th ed. Washington (DC): American Public Health Association; 2008. p. 230–1.
-
- Wagener DJT, van Tongeren JHM, Meuwissen JHET. Fasciola hepatica infection; an unusual cause of severe anemia [in Dutch]. Ned Tijdschr Geneeskd. 1972;116:431–5. - PubMed
-
- Borgsteede FHM, Moll L, Vellema P, Gaasenbeek CPH. Lack of reversion in triclabendazole-resistant Fasciola hepatica. Vet Rec. 2005;156:350–1. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources